Cybin announces grant of u.s. patent covering its proprietary compound cyb004 (deuterated dmt) for the treatment of anxiety disorders

Toronto--(business wire)--cybin announces grant of u.s. patent covering its proprietary compound cyb004 (deuterated dmt) for the treatment of anxiety disorders
CYBN Ratings Summary
CYBN Quant Ranking